We are Sorry, This Page doesn't Exist
Concert Pharmaceuticals sells VX-561 milestones for $32M to Vertex
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
EULAV Asset Management Buys Vertex Pharmaceuticals Inc, DraftKings Inc, Exelixis Inc, Sells ...
Related Stocks: VRTX, EXEL, V, BAC, JPM, HD, DKNG, ITRI, VSTO, SEM, ALXN, SBA,.....»»
Vertex Pharmaceuticals backs FY21 revenue view $6.7B-$6.9B, consensus $6.95B
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals reports Q1 EPS $2.98, consensus $2.69
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals announces EC approval for Kaftrio label extension
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals, Obsidian enter research and license agreement
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Society for Clinical Research Sites to hold a virtual summit Vertex Pharmaceuticals
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex to study experimental gene-editing therapy as treatment for sickle cell, beta-thalassemia
Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»
Vertex Pharmaceuticals receives CHMP recommendation for Kaftrio label extension
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex to begin Phase 1/2 trial of treatment for people with type 1 diabetes
Shares of Vertex Pharmaceuticals Inc. were down 0.2% in trading on Wednesday after the company said it started an early-stage clinical t.....»»
Barron"s Latest Picks And Pans: Lowe"s, Microsoft, Vertex Pharmaceuticals, ViacomCBS And More
This weekend's Barron's provides some insight into Cathie Wood, one of Barron's 100 most influential women in the United States this year. read more.....»»
Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals price target lowered to $280 from $285 at Credit Suisse
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex CEO says company is seeking to make "transformative" deals
Shares of Vertex Pharmaceuticals Inc. were down 4.3% in trading on Tuesday, the day after the company discussed its deal-making strategy with analysts during its fourth-quarter earnings call. The company said it is considering buying companies wi.....»»
Vertex Pharmaceuticals price target lowered to $284 from $302 at BMO Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals price target lowered to $275 from $315 at H.C. Wainwright
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals price target raised to $347 from $307 at Piper Sandler
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Pharmaceuticals sees FY21 product revenue $6.7B-$6.9B
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»